Exogenous irritant-induced airway hyperreactivity and inhibition of soluble guanylyl cyclase

Biological Research for Nursing

Volumn 10, Issue 2, 2008, Pages 93-101

  Antoov, Martina ^a   Strapkov, Anna ^a   Turáň, Tom ^b  

^a University Hospital in Martin   (Slovakia)

^b FACULTY HOSPITAL   (Slovakia)

Author keywords

Airway reactivity; cGMP; Nitric oxide; Soluble guanylyl cyclase

Indexed keywords

GUANYLATE CYCLASE; IRRITANT AGENT; METHYLENE BLUE; TOLUENE;

ANIMAL; ARTICLE; BRONCHUS HYPERREACTIVITY; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; EXPOSURE; GUINEA PIG; MALE; SOLUBILITY;

ANIMALS; BRONCHIAL HYPERREACTIVITY; GUANYLATE CYCLASE; GUINEA PIGS; INHALATION EXPOSURE; IRRITANTS; MALE; METHYLENE BLUE; SOLUBILITY; TOLUENE;

EID: 52349107181     PISSN: 10998004     EISSN: 15524175     Source Type: Journal    
DOI: 10.1177/1099800408323846     Document Type: Article

References (34)

1. Antoov, M., Turan, T., Strapkov, A., & Nosov, G. (2005). Inhibition of guanylyl cyclase in the airways hyperreaktivity. Bratislavsk Lekrske Listy, 106 (8-9). 243-247.
2. Bellamy, T.C., Wood, J., & Garthwait, J. (2002). On the activation of soluble guanylyl cyclase by nitric oxide. Proceedings of the National Academy of Sciences, 99 (1). 507-510.
3. Belik, J., Hehne, N., Pan, J., & Behrends, S. (2007). Soluble guanylate cyclase-dependent relaxation is reduced in the adult rat bronchial smooth muscle. American Journal of Physiology, Lung Cell Molecular Physiology, 292, L699 - L703.
4. Directive of European Commission 86/609/EEC on the protection of animals used for experimental and other scientific purposes (1986). The official bulletin of European Partnership.
5. Denniger, J.W., & Marletta, M.A. (1999). Guanylate cyclase and the NO/cGMP signaling pathway. Biochimica Biophysica Acta, 1411, 334-350.
6. Ellis, J.L. (1997). Role of soluble guanylyl cyclase in the relaxations to nitric oxide donor and to nonadrenergic nerve stimulation in guinea pig trachea and human bronchus. Pharmacology and Experimental Therapeutics, 280 (3). 1215-1281.
7. Evgenov, O.V., Evgenov, N.V., Mollnes, T.E., & Bjertnaes, L.J. (2002). Methylene blue reduces pulmonary oedema and cyclooxygenase products in endotoxaemic sheep. European Respiratory Journal, 20, 957-964.
8. Friebe, A., & Koesling, D. (2003). Regulation of nitric oxide-sensitive guanylyl cyclase. Circulation Research, 93, 96-105.
9. Hamad, A.M., Clayton, A., Islam, B., & Knox, A.J. (2003). Guanylyl cyclases, nitric oxide, natriuretic peptides, and airway smooth muscle function. American Journal of Physiology, Lung Cell Molecular Physiology, 285, L973 - L983.
10. Hobbs, A.J. (1997). Soluble guanylate cyclase: The forgotten sibling. Trends in Pharmacological Science, 18, 484-491.
11. Ignarro, L.J. (1991). Signal transduction mechanisms involving nitric oxide. Biochemical Pharmacology, 41, 485-490.
12. Jones, K.A., Wong, G.Y., Jankowski, Ch J., Akao, M., & Warner, D.O. (1999). cGMP modulation of Ca2+ sensitivity in airway smooth muscle. American Journal of Physiology, Lung Cell Molecular Physiology, 276, L35 - L40.
13. Kagan, V.E., & Laskin, J.D. (2001). Direct and indirect antioxidant effects of nitric oxide: Radically unsettled issues. Antioxidants Redox Signaling, 3 (2). 173-175.
14. Klabunde, R.E., Tse, J., & Weiss, H.R. (1998). Guanylyl cyclase inhibition reduces contractility and decreases cGMP and cAMP in isolated rat hearts. Cardiovascular Research, 37, 676-683.
15. Koesling, D., Russwurm, M., Mergia, E., Mullershausen, F., & Friebe, A. (2004). Nitric oxide-sensitive guanylyl cyclase: Structure and regulation. Neurochemistry International, 45, 813-819.
16. Law No. 289/2003 Statute-book Regulation of Slovak Republic government about requirements on the protection of animals used for experimental and other scientific purposes.
17. Leigh, R., Ellie, R., Wattie, J., Donaldson, D.D., & Inman, M.D. (2004). Is interleukin-13 critical in maintaining airway hyperresponsiveness in allergen-challenged mice ? American Journal of Respiratory and Critical care Medicine, 170, 851-856.
18. Mattia, C.J., Lebel, C.P., & Bondy, S.C. (1991). Effects of toluene and its metabolites on cerebral reactive oxygen species generation. Biochemical Pharmacology, 42, 879-882.
19. Mokr, J. (2006). The mechanisms of contraction and relaxation airways smooth muscle [Article in Slovak]. Studia Pneumologica Phthiseologica, 6, 258-270.
20. Murad, F. (1999). Discovery of some of the biological effects of nitric oxide and its role in cell signaling. Bioscience Reports, 19 (3). 133-154.
21. Nakane, M. (2003). Soluble guanylyl cyclase: Physiological role as an NO receptor and the potential molecular target for therapeutic application. Clinical Chemistry and Laboratory Medicine, 41 (7). 865-870.
22. Osanai, T., Fujita, N., Fujiwara, N., Nakano, T., Takahashi, K., Guan, W., & Okumura, K. (2000). Cross talk of shear-induced production of prostacyclin and nitric oxide in endothelial cells. American Journal of Physiology, Heart and Circulatory Physiology, 278, H233 - H238.
23. Papapetropoulos, A., Simoes, D.C.M., Xanthou, G., Roussos, Ch., & Gratziou, Ch. (2005). Soluble guanylyl cyclase expression is reduced in allergic asthma. American Journal of Physiology, Lung Cell Molecular Physiology, 290, L179 - L184.
24. Perkins, W.J., Pabelick, C., Warner, D.O., & Jones, K.A. (1998). cGMP-independent mechanism of airway smooth muscle relaxation induced by S-nitrosoglutathione. American Journal of Physiology, Cell Physiology, 275, C468 - C474.
25. Ricciardolo, F.L.M., Sterk, P.J., Gaston, B., & Folkerts, G. (2004). Nitric oxide in health and disease of the respiratory system. Physiological Research, 84, 731-765.
26. Roy, B., & Garthwaite, J. (2006). Nitric oxide activation of guanylyl cyclase in cells revisited. Proceedings of the National Academy of Sciences, 103 (32). 12185-12190.
27. Sadeghi-Hashjin, G., Folkerts, G., Henrics, P.A., van der Loo, P.G., van der Linde, H.J., Dik, I.E., & Nijkamp, F.P. (1996). Induction of guinea pig airway hyperresponsiveness by inactivation of guanylate cyclase. European Journal of Pharmacology, 302, 109-115.
28. Salaris, S.C., Babbs, C.F., & Voorheesiiw, D. (1991). Methylene blue as an inhibitor of superoxide generation by xanthine oxidase. Biochemical Pharmacology, 42, 499.
29. Schuiling, M., Meurs, H., Zuidhof, A.B., Venea, N., & Zaagsma, J. (1998). Dual action of iNOS-derived nitric oxide in allergen-induced airway hyperreactivity in conscious, unrestrained guinea pigs. American Journal of Respiratory and Critical Care Medicine, 158, 1442-1449.
30. Somlyo, A.P., & Somlyo, A.V. (1994). Signal transduction and regulation in smooth muscle. Nature, 372, 231-236.
31. Strapkov, A., Nosov, G., & Hanek, J. (1996). Effect of irritants on airways reactivity. Central European Journal of Public Health, 4, 54-56.
32. Stuart-Smith, K., Bynoe, T.C., Lindeman, K.S., & Hirshman, C.A. (1994). Differential effects of nitrovasodilators and nitric oxide on porcine tracheal and bronchial muscle in vivo. Journal of Applied Physiology, 341, 225-233.
33. Weingartner, R., Oliveira, E.S., Sant Anna, R.P., Oliveira, R.P., Azambuja, L.A., & Friedman, G. (1999). Blockade of the action of nitric oxide in human septic shock increases systemic vascular resistance and has detrimental effect on pulmonary function after a short infusion of methylene blue. Brazilian Journal of Medical and Biological Research, 32, 1505-1513.
34. Weinbroum, A.A., Goldin, I., Kluger, Y., & Szold, A. (2002). Methylene blue in preventing hemodynamic and metabolic derangement following superior mesenteric artery clamping/unclamping: An intratracheal vs. intraperitoneal dose-response study. Shock, 17 (5). 372-376.